90
Participants
Start Date
May 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
March 31, 2027
ONO-2020
ONO-2020 group: Two ONO-2020 tablets will be orally administered once daily.
Placebo
Two ONO-2020 placebo tablets will be orally administered once daily
NOT_YET_RECRUITING
Hotei Hospital, Aichi
RECRUITING
Akita Prefectural Center For Rehabilitation and Psychiatric Medicine, Akita
RECRUITING
Medical Corporation Keishinkai Kyowa Hospital, Akita
RECRUITING
Aiseikai General Incorporated Foundation, Hirosaki Aiseikai Hospital, Aomori
RECRUITING
Seinan Hospital, Aomori
NOT_YET_RECRUITING
Matsubara Hospital, Fukui
RECRUITING
Aburayama Hospital, Fukuoka
RECRUITING
Kuramitsu Hospital, Fukuoka
NOT_YET_RECRUITING
Kishikai Kishi Hospital, Gunma
NOT_YET_RECRUITING
Hayakawa Clinic, Hiroshima
NOT_YET_RECRUITING
Koseikai Cocoro Hospital Kusatsu, Hiroshima
NOT_YET_RECRUITING
Nakamura Hospital, Hiroshima
NOT_YET_RECRUITING
Ishiki Hospital, Kagoshima
NOT_YET_RECRUITING
Fujisawahospital, Kanagawa
RECRUITING
Hatano Kousei Hospital, Kanagawa
RECRUITING
Showa Medical University Northern Yokohama Hospital, Kanagawa
RECRUITING
Maizuru Medical Center, Kyoto
RECRUITING
Iryohojin Shadan Shoshinkai Morinohosupitaru・Aoba, Miyagi
NOT_YET_RECRUITING
Jizenkai Ando Hospital, Nagano
RECRUITING
Nagaokai Neyagawa Sanatorium, Osaka
RECRUITING
Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital, Osaka
RECRUITING
Hizen Psychiatric Center, Saga
RECRUITING
Rainbow & Sea Hospital, Saga
RECRUITING
Asuka Hospital, Tokyo
RECRUITING
Nishigahara Hospital, Tokyo
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY